½ÃÀ庸°í¼­
»óǰÄÚµå
1587341

±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : Á¦Ç° À¯Çü, ÁõÈıº À¯Çü, ÇØºÎÇÐ, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Compartment Syndrome Monitoring Devices Market by Product, Syndrome Type, Anatomy, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 192 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2023³â¿¡ 3¾ï 4,715¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 3¾ï 7,560¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 8.59%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 6¾ï 1,815¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ Àåºñ´Â ±¸È¹ÁõÈıºÀ» Áø´ÜÇÏ°í °ü¸®ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ±¸È¹ÁõÈıºÀº ±ÙÀ° ±¸È¹ÀÇ ¾Ð·ÂÀÌ Áõ°¡Çϸé Ç÷¾× ¼øÈ¯ÀÌ ³ªºüÁ® ±ÙÀ°°ú ½Å°æ ¼Õ»óÀ» ÃÊ·¡ÇÒ ¼ö ÀÖ´Â ½É°¢ÇÑ »óÅÂÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡ÀÇ Çʿ伺Àº ¿µ±¸ÀûÀÎ ¼Õ»óÀ̳ª Àý´ÜÀ» ¹æÁöÇϱâ À§ÇØ Á¤È®ÇÑ ¾Ð·Â ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇϱ⠶§¹®¿¡ ¿Ü»ó Ä¡·á, Á¤Çü¿Ü°ú ¼ö¼ú ¹× ½ºÆ÷Ã÷ ÀÇÇп¡¼­ ÇʼöÀûÀÎ ¿ä¼Ò·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. º´¿ø, ÀÀ±Þ½Ç, Àü¹® Ŭ¸®´Ð¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëµÇ¾î Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ°ú Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±â ½ÃÀåÀº ¿Ü»ó »ç·Ê Áõ°¡¿Í ¿¹¹æÀû °Ç°­ °ü¸® Áõ°¡¿¡ Å©°Ô ¿µÇâÀ» ¹Þ¾Æ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼¾¼­ ±â¼úÀÇ ¹ßÀü°ú ¹«¼± ±â´ÉÀÇ ÅëÇÕÀ¸·Î ÀÌ·¯ÇÑ ±â±âÀÇ Á¤È®¼º°ú ÆíÀǼºÀÌ Çâ»óµÇ¾î »ç¿ë ¹üÀ§°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ºñÁî´Ï½º ±âȸ´Â ÀÇ·á ÀÎÇÁ¶ó°¡ ¹ßÀüÇϰí ÀÇ·áºñ ÁöÃâÀÌ Áõ°¡ÇÏ´Â ½ÅÈï ½ÃÀå¿¡¼­ ãÀ» ¼ö ÀÖ½À´Ï´Ù. ȯÀÚ Ä£È­ÀûÀÌ°í ´ú ħ½ÀÀûÀÎ ÀÇ·á±â±âÀÇ ¸ÂÃãÈ­´Â Å« ¼ºÀå ±âȸ°¡ µÉ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº ºñ¿ë, ±ÔÁ¦ À庮, ÀåºñÀÇ ¿Ã¹Ù¸¥ »ç¿ë¹ýÀ» À§ÇÑ ±³À°ÀÌ ÇÊ¿äÇÏ´Ù´Â Á¡ µîÀÌ ½ÃÀå ¼ºÀåÀÇ °É¸²µ¹·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¼ÒÇüÈ­ ±â¼ú, ½Ç½Ã°£ µ¥ÀÌÅÍ ºÐ¼®, ÀΰøÁö´É ÅëÇÕ µîÀÇ ¹ßÀüÀº ȹ±âÀûÀÎ ¹ßÀüÀ» °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. ÇÏÀÌÅ×Å© ±â¾÷°úÀÇ Çù¾÷À» ÃËÁøÇϸé Áø´Ü Á¤È®µµ¸¦ Çâ»ó½Ãų ¼ö ÀÖ´Â ºñ¿ë È¿À²ÀûÀΠ÷´Ü ¼Ö·ç¼ÇÀ» °³¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå µ¿ÇâÀ» Áö¼ÓÀûÀ¸·Î ºÐ¼®ÇÏ°í °æÁ¦¼º°ú Á¢±Ù¼º¿¡ ÃÊÁ¡À» ¸ÂÃá Àü·«À» äÅÃÇϸé ÇѰ踦 ¿ÏÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ Æ¯¼ºÀº ¿ªµ¿ÀûÀ̸ç, ±â¼ú ¹ßÀü°ú ÀÇ·á Á¤Ã¥ÀÇ º¯È­¿¡ ¿µÇâÀ» ¹Þ±â ¶§¹®¿¡ ±â¾÷Àº ¹ÎøÇÏ°í ¹Ì·¡ÁöÇâÀûÀÎ Á¢±ÙÀÌ ÇÊ¿äÇÕ´Ï´Ù. Á¦Ç° Ư¼ºÀ» Çõ½ÅÇϱâ À§ÇØ Ã¶ÀúÇÑ ¿¬±¸°³¹ßÀ» ÅëÇØ ¼ºÀåÀ» À¯ÁöÇÏ°í °æÀï ¿ìÀ§¸¦ À¯ÁöÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 3¾ï 4,715¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 3¾ï 7,560¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 6¾ï 1,815¸¸ ´Þ·¯
CAGR(%) 8.59%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ Àåºñ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ¸·Î ÀÎÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ºÆ÷Ã÷ ºÎ»ó ¹× ¿Ü»ó Áõ°¡
    • º¹°­ ³» °íÇ÷¾ÐÀÇ À¯º´·ü Áõ°¡
    • Á¤Çü¿Ü°ú ÀÀ±Þ»óȲ¿¡¼­ ±Þ¼º ±¸È¹ÁõÈıºÀÇ Á¤È®ÇÏ°í ½Ã±âÀûÀýÇÑ Áø´ÜÀÇ Çʿ伺
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • CSM ÀåºñÀÇ ³ôÀº ºñ¿ë°ú Á¤È®¼ºÀÇ ÇѰè
  • ½ÃÀå ±âȸ
    • ±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ ÀåºñÀÇ È¿°ú¸¦ Çâ»ó½ÃŰ´Â »õ·Î¿î ±â¼ú
    • ¸ð´ÏÅ͸µ ±â±â ºÐ¾ßÀÇ ºü¸¥ ¿¬±¸ ¹× °³¹ß
  • ½ÃÀå °úÁ¦
    • Á¤È®ÇÑ ¾Ð·Â ÃøÁ¤ÀÇ º¹À⼺¿¡ ´ëÇÑ ¿ì·Á

Portre's Five Forces: ±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ Àåºñ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ Àåºñ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÏ¿© º¥´õ°¡ Ä¡¿­ÇÑ °æÀï¿¡¼­ ÀÚ½ÅÀÇ À§Ä¡¸¦ °­È­Çϱâ À§ÇÑ Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ Àåºñ ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ Àåºñ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ ±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : Á¦Ç°º°

  • ÀÏȸ¿ëǰ ¶Ç´Â ºÎ¼Óǰ
  • ±¸È¹ ³»¾Ð ¸ð´ÏÅ͸µ ½Ã½ºÅÛ
  • ±ÙÀ°³» Á¶Á÷¾Ð ÃøÁ¤ Ä«Å×ÅÍ

Á¦7Àå ±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ÁõÈıº À¯Çüº°

  • º¹ºÎ ±¸È¹ÁõÈıº
  • ±Þ¼º ±¸È¹ÁõÈıº
  • ¸¸¼º ±¸È¹ÁõÈıº

Á¦8Àå ±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ÇØºÎÇк°

  • º¹ºÎ
  • ÇÏÁö
  • »óÁö

Á¦9Àå ±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • º´¿ø ¹× Ŭ¸®´Ð

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ ±â±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ ±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ±¸È¹ÁõÈıº ¸ð´ÏÅ͸µ ±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Becton, Dickinson, and Company
  • Biometrix Ltd.
  • C2DX, Inc.
  • ConvaTec Inc.
  • Medline Industries, Inc.
  • MedStack
  • Millar, Inc.
  • MY01, Inc.
  • Potrero Medical, Inc.
  • Raumedic AG
  • Spiegelberg GmbH & Co. KG
  • Terumo Corporation
LSH

The Compartment Syndrome Monitoring Devices Market was valued at USD 347.15 million in 2023, expected to reach USD 375.60 million in 2024, and is projected to grow at a CAGR of 8.59%, to USD 618.15 million by 2030.

Compartment Syndrome Monitoring Devices are crucial in diagnosing and managing compartment syndrome, a serious condition where increased pressure within a muscle compartment reduces circulation, potentially leading to muscle and nerve damage. The need for these devices is driven by the necessity for precise pressure monitoring to prevent permanent damage or amputation, making them vital in trauma care, orthopedic surgeries, and sports medicine. Their application extends to hospitals, emergency care settings, and specialized clinics, where they aid in continuous monitoring and timely intervention. The market for these devices is expanding, influenced heavily by the increase in trauma cases and the rise in preventative healthcare practices. Moreover, advancements in sensor technology and the integration of wireless features are making these devices more accurate and convenient, broadening their use scope. Key opportunities lie in emerging markets with evolving healthcare infrastructure and increased healthcare spending. Tailoring devices to be more patient-friendly and less invasive represents a significant growth opportunity. However, market growth is challenged by high costs, regulatory hurdles, and the need for significant training for proper device use. The potential for innovation is substantial: development in miniaturization technology, real-time data analytics, and artificial intelligence integration could offer breakthroughs. Fostering collaborations with tech companies could yield sophisticated, cost-effective solutions that enhance diagnostic accuracy. Continuous analysis of market trends and adopting strategies focusing on affordability and accessibility can mitigate limitations. The nature of the market is dynamic, influenced by technological advancements and healthcare policy changes, requiring businesses to be agile and forward-thinking in their approach. Engaging in rigorous R&D to innovate product features will sustain growth and maintain competitive advantage.

KEY MARKET STATISTICS
Base Year [2023] USD 347.15 million
Estimated Year [2024] USD 375.60 million
Forecast Year [2030] USD 618.15 million
CAGR (%) 8.59%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Compartment Syndrome Monitoring Devices Market

The Compartment Syndrome Monitoring Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of sports injuries and traumatic events
    • Growing prevalence of intra-abdominal hypertension
    • Need for accurate and timely diagnosis of acute compartment syndrome in orthopedic emergency
  • Market Restraints
    • High cost of CSM devices and accuracy limitations
  • Market Opportunities
    • Emerging technologies to improve efficacy of compartment syndrome monitoring devices
    • Rapid R&D in the field of monitoring devices
  • Market Challenges
    • Concerns regarding complexity in measuring accurate pressure

Porter's Five Forces: A Strategic Tool for Navigating the Compartment Syndrome Monitoring Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Compartment Syndrome Monitoring Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Compartment Syndrome Monitoring Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Compartment Syndrome Monitoring Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Compartment Syndrome Monitoring Devices Market

A detailed market share analysis in the Compartment Syndrome Monitoring Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Compartment Syndrome Monitoring Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Compartment Syndrome Monitoring Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Compartment Syndrome Monitoring Devices Market

A strategic analysis of the Compartment Syndrome Monitoring Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Compartment Syndrome Monitoring Devices Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson, and Company, Biometrix Ltd., C2DX, Inc., ConvaTec Inc., Medline Industries, Inc., MedStack, Millar, Inc., MY01, Inc., Potrero Medical, Inc., Raumedic AG, Spiegelberg GmbH & Co. KG, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Compartment Syndrome Monitoring Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Disposables or Accessories, Intra-Compartmental Pressure Monitoring Systems, and Intramuscular Tissue Pressure Measuring Catheters.
  • Based on Syndrome Type, market is studied across Abdominal Compartment Syndrome, Acute Compartment Syndrome, and Chronic Compartment Syndrome.
  • Based on Anatomy, market is studied across Abdomen, Lower Extremities, and Upper Extremities.
  • Based on End-User, market is studied across Ambulatory Surgical Centres and Hospital & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of sports injuries and traumatic events
      • 5.1.1.2. Growing prevalence of intra-abdominal hypertension
      • 5.1.1.3. Need for accurate and timely diagnosis of acute compartment syndrome in orthopedic emergency
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of CSM devices and accuracy limitations
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging technologies to improve efficacy of compartment syndrome monitoring devices
      • 5.1.3.2. Rapid R&D in the field of monitoring devices
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding complexity in measuring accurate pressure
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Compartment Syndrome Monitoring Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Disposables or Accessories
  • 6.3. Intra-Compartmental Pressure Monitoring Systems
  • 6.4. Intramuscular Tissue Pressure Measuring Catheters

7. Compartment Syndrome Monitoring Devices Market, by Syndrome Type

  • 7.1. Introduction
  • 7.2. Abdominal Compartment Syndrome
  • 7.3. Acute Compartment Syndrome
  • 7.4. Chronic Compartment Syndrome

8. Compartment Syndrome Monitoring Devices Market, by Anatomy

  • 8.1. Introduction
  • 8.2. Abdomen
  • 8.3. Lower Extremities
  • 8.4. Upper Extremities

9. Compartment Syndrome Monitoring Devices Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centres
  • 9.3. Hospital & Clinics

10. Americas Compartment Syndrome Monitoring Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Compartment Syndrome Monitoring Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Compartment Syndrome Monitoring Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Becton, Dickinson, and Company
  • 2. Biometrix Ltd.
  • 3. C2DX, Inc.
  • 4. ConvaTec Inc.
  • 5. Medline Industries, Inc.
  • 6. MedStack
  • 7. Millar, Inc.
  • 8. MY01, Inc.
  • 9. Potrero Medical, Inc.
  • 10. Raumedic AG
  • 11. Spiegelberg GmbH & Co. KG
  • 12. Terumo Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦